CRY2olig-PR
(Plasmid
#218917)
-
PurposeExpression of CRY2olig-mCherry fused to a codon-optimised poly-PR sequence
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 218917 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backboneCRY2olig-mCherry #60032
- Backbone size w/o insert (bp) 6188
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCRY2olig-mCherry tagged poly-PR
-
SpeciesH. sapiens (human)
-
Mutationwild-type
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BsrGI (unknown if destroyed)
- 3′ cloning site NotI (unknown if destroyed)
- 5′ sequencing primer CMV
- 3′ sequencing primer SV40pA-R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
CRY2olig-PR was a gift from Tatyana Shelkovnikova (Addgene plasmid # 218917 ; http://n2t.net/addgene:218917 ; RRID:Addgene_218917) -
For your References section:
C9orf72 poly-PR forms anisotropic condensates causative of nuclear TDP-43 pathology. Hodgson RE, Rayment JA, Huang WP, Sanchez Avila A, Ellis BCS, Lin YH, Soni N, Hautbergue GM, Shelkovnikova TA. iScience. 2024 Sep 14;27(10):110937. doi: 10.1016/j.isci.2024.110937. eCollection 2024 Oct 18. 10.1016/j.isci.2024.110937 PubMed 39391721